Cell cycle analysis performed by flow cytometry after 24 hours in cells treated with TRAIL or His peptide in the absence or presence of inhibitors
Treatment . | Percentage of cells . | ||
---|---|---|---|
G1 . | S . | G2/M . | |
His peptide | 50 | 29 | 21 |
His peptide + z-VAD | 49 | 30 | 21 |
His peptide + L-NAME | 51 | 29 | 20 |
TRAIL | 41 | 41 | 18 |
TRAIL + z-VAD | 51 | 29 | 20 |
TRAIL + L-NAME | 47 | 32 | 21 |
Treatment . | Percentage of cells . | ||
---|---|---|---|
G1 . | S . | G2/M . | |
His peptide | 50 | 29 | 21 |
His peptide + z-VAD | 49 | 30 | 21 |
His peptide + L-NAME | 51 | 29 | 20 |
TRAIL | 41 | 41 | 18 |
TRAIL + z-VAD | 51 | 29 | 20 |
TRAIL + L-NAME | 47 | 32 | 21 |
The percentage of cells with a G1(2n), S, G2/M(4n) DNA content were calculated excluding apoptotic cells. Data represent the means of 3 separate experiments. SDs were comprised within 10% of the means and are omitted for clarity.